RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 100 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,430,000 | -25.9% | 4,382,306 | +14.2% | 0.00% | -33.3% |
| Q3 2016 | $14,084,000 | +76.6% | 3,837,675 | +7.3% | 0.00% | +50.0% |
| Q2 2016 | $7,974,000 | +11.8% | 3,575,734 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $7,130,000 | -30.3% | 3,427,862 | +1.5% | 0.00% | 0.0% |
| Q4 2015 | $10,228,000 | +82.0% | 3,375,731 | +48.3% | 0.00% | +100.0% |
| Q3 2015 | $5,621,000 | -23.9% | 2,275,817 | -1.1% | 0.00% | -50.0% |
| Q2 2015 | $7,390,000 | -12.8% | 2,302,248 | -3.0% | 0.00% | 0.0% |
| Q1 2015 | $8,470,000 | +55.3% | 2,372,617 | -1.3% | 0.00% | +100.0% |
| Q4 2014 | $5,455,000 | -11.3% | 2,403,188 | -24.2% | 0.00% | -50.0% |
| Q3 2014 | $6,149,000 | -48.0% | 3,169,478 | -2.7% | 0.00% | -33.3% |
| Q2 2014 | $11,825,000 | -13.0% | 3,257,486 | -7.0% | 0.00% | -25.0% |
| Q1 2014 | $13,588,000 | +39.5% | 3,501,972 | +2.5% | 0.00% | +33.3% |
| Q4 2013 | $9,741,000 | -34.8% | 3,418,046 | -18.1% | 0.00% | -40.0% |
| Q3 2013 | $14,941,000 | +16.1% | 4,173,390 | +8.3% | 0.01% | 0.0% |
| Q2 2013 | $12,871,000 | – | 3,853,482 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |